Journey Medical Corp Stock Buy Hold or Sell Recommendation
| DERM Stock | USD 6.11 0.19 3.21% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Journey Medical Corp is 'Cautious Hold'. The recommendation algorithm takes into account all of Journey Medical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Journey Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Journey and provide practical buy, sell, or hold advice based on investors' constraints. Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Journey |
Execute Journey Medical Buy or Sell Advice
The Journey recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Journey Medical Corp. Macroaxis does not own or have any residual interests in Journey Medical Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Journey Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
30 Days |
Risk Tolerance
I am an educated risk taker |
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Journey Medical Trading Alerts and Improvement Suggestions
| Journey Medical Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 56.13 M. Net Loss for the year was (14.67 M) with profit before overhead, payroll, taxes, and interest of 35.26 M. | |
| Journey Medical Corp currently holds about 38.14 M in cash with (9.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17. | |
| Journey Medical Corp has a frail financial position based on the latest SEC disclosures | |
| Roughly 28.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Journey Medical Announces Earnings Results |
Journey Medical Returns Distribution Density
The distribution of Journey Medical's historical returns is an attempt to chart the uncertainty of Journey Medical's future price movements. The chart of the probability distribution of Journey Medical daily returns describes the distribution of returns around its average expected value. We use Journey Medical Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Journey Medical returns is essential to provide solid investment advice for Journey Medical.
| Mean Return | 0.50 |
| Value At Risk | -5.25 |
| Potential Upside | 8.05 |
| Standard Deviation | 4.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Journey Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Journey Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Journey Medical, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Journey Medical Corp back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | |||
| Atria Investments Llc | 2024-12-31 | 43.4 K | |
| Gladstone Institutional Advisory Llc | 2024-12-31 | 30 K | |
| State Street Corp | 2024-12-31 | 29 K | |
| Neuberger Berman Group Llc | 2024-12-31 | 28.5 K | |
| Kovitz Investment Group Partners, Llc | 2024-12-31 | 24.7 K | |
| Brighton Jones Llc | 2024-12-31 | 23 K | |
| Ubs Group Ag | 2024-12-31 | 22.4 K | |
| Org Wealth Partners, Llc | 2024-12-31 | 20.9 K | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 20.5 K | |
| Tang Capital Management Llc | 2024-12-31 | 1.7 M | |
| Cambridge Invest Research Advisors, Inc. | 2024-12-31 | 328.1 K |
Journey Medical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (547K) | (8.5M) | 1.7M | 4.0M | (4.2M) | (4.4M) | |
| Change In Cash | 3.4M | 40.8M | (17.1M) | (4.6M) | (7.1M) | (6.8M) | |
| Free Cash Flow | 3.9M | (12.2M) | (33.5M) | 240K | (9.1M) | (9.6M) | |
| Depreciation | 1.5M | 2.6M | 4.4M | 3.9M | 3.7M | 3.9M | |
| Other Non Cash Items | 747K | 20.5M | 1.1M | 4.3M | (4.3M) | (4.1M) | |
| Capital Expenditures | 1.2M | 10M | 20M | 5M | 15M | 15.8M | |
| Net Income | 5.3M | (44.0M) | (29.6M) | (3.9M) | (14.7M) | (15.4M) | |
| End Period Cash Flow | 8.2M | 49.1M | 32.0M | 27.4M | 20.3M | 19.3M | |
| Investments | (1.2M) | (10M) | (20M) | (5M) | (15M) | (14.3M) |
Journey Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Journey Medical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Journey Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Journey stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.55 | |
β | Beta against Dow Jones | 1.10 | |
σ | Overall volatility | 4.49 | |
Ir | Information ratio | 0.12 |
Journey Medical Volatility Alert
Journey Medical Corp shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Journey Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Journey Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Journey Medical Fundamentals Vs Peers
Comparing Journey Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Journey Medical's direct or indirect competition across all of the common fundamentals between Journey Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Journey Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Journey Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Journey Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Journey Medical to competition |
| Fundamentals | Journey Medical | Peer Average |
| Return On Equity | -0.73 | -0.31 |
| Return On Asset | -0.0816 | -0.14 |
| Profit Margin | (0.26) % | (1.27) % |
| Operating Margin | 0.42 % | (5.51) % |
| Current Valuation | 121.03 M | 16.62 B |
| Shares Outstanding | 14.89 M | 571.82 M |
| Shares Owned By Insiders | 27.65 % | 10.09 % |
| Shares Owned By Institutions | 23.49 % | 39.21 % |
| Number Of Shares Shorted | 94.09 K | 4.71 M |
| Price To Earning | (9.50) X | 28.72 X |
| Price To Book | 11.32 X | 9.51 X |
| Price To Sales | 2.27 X | 11.42 X |
| Revenue | 56.13 M | 9.43 B |
| Gross Profit | 35.26 M | 27.38 B |
| EBITDA | (13.68 M) | 3.9 B |
| Net Income | (14.67 M) | 570.98 M |
| Cash And Equivalents | 38.14 M | 2.7 B |
| Cash Per Share | 2.17 X | 5.01 X |
| Total Debt | 201 K | 5.32 B |
| Debt To Equity | 0.61 % | 48.70 % |
| Current Ratio | 1.40 X | 2.16 X |
| Book Value Per Share | 1.04 X | 1.93 K |
| Cash Flow From Operations | (9.13 M) | 971.22 M |
| Short Ratio | 2.30 X | 4.00 X |
| Earnings Per Share | (0.92) X | 3.12 X |
| Price To Earnings To Growth | (0.04) X | 4.89 X |
| Target Price | 9.88 | |
| Beta | 0.98 | -0.15 |
| Market Capitalization | 127.64 M | 19.03 B |
| Total Asset | 80.24 M | 29.47 B |
| Retained Earnings | (87.03 M) | 9.33 B |
| Working Capital | 13 M | 1.48 B |
| Current Asset | 217.23 M | 9.34 B |
Note: Acquisition by Smith Justin Adam of 30000 shares of Journey Medical at 3.47 subject to Rule 16b-3 [view details]
Journey Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Journey . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Journey Medical Buy or Sell Advice
When is the right time to buy or sell Journey Medical Corp? Buying financial instruments such as Journey Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Journey Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 446 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Journey Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.